IDEAYA Biosciences

IDEAYA Biosciences

  • Founded: 2015
  • Location: South SF, CA
  • Employee range: 50 - 200
  • Clinical stage: Clin2
  • Therapy area: Uveal melanoma (partner: Pfizer)
  • Drug types: ONC
  • Lead product: Darovasertib
  • Product link:
  • Funding: $201M stock Apr 2023; $86M stock Jul 2021; $57.5M IPO May 2019; $94M B Mar 2018; $46M A Apr 2016

job board

Short description:

Personalized Synthetic Medicines

Drug notes:

IDE397 Clin2 NSCLC, esophagogastric cancer, Clin1 solid tumors (partner: Amgen); IDE161 Clin1 breast, ovarian cancers; 4 add'l products RD cancer

Long description:

IDEAYA Biosciences is using synthetic lethality to design therapeutics for cancer. Synthetic lethality is a situation where inhibition of two genes together - but not each individually - results in cell death. IDEAYA is exploiting synthetic lethality interactions to identify a novel set of drug targets across different organisms and in human tumor cells. To achieve this, IDEAYA is using their DECIPHER Dual CRISPR Synthetic Lethality library with proprietary data and collaborations with the Broad Institute of Harvard and MIT. IDEAYA has a diverse pipeline of drugs in clinical stage development for a variety of solid tumors.


IDEAYA Biosciences
Medical Director (Early Development)
South San Francisco, CA San Diego, California/ On-site|21 days ago
IDEAYA Biosciences
Senior/Principal Research Scientist Compound Manag...
South San Francisco, CA/ On-site|28 days ago
IDEAYA Biosciences
Director/Senior Director, DMPK and Clinical Pharma...
South San Francisco, CA/ On-site|37 days ago
IDEAYA Biosciences
Payroll Manager
South San Francisco, CA/ Hybrid|49 days ago
IDEAYA Biosciences
Research Scientist/Senior Research Scientist
South San Francisco, CA/ On-site|56 days ago
IDEAYA Biosciences
Vice President, Corporate Strategy and Business De...
San Francisco, CA|100+ days ago
IDEAYA Biosciences
Director / Sr Director, Medicinal Chemistry
San Francisco, CA|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy